Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Frew

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Dermatology|September 16, 2021
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspectsDillon Mintoff, Farida Benhadou, Nikolai P Pace, et al.
Experimental Dermatology|March 8, 2020
Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?John W Frew, David Grand, Kristina Navrazhina, et al.
The Australasian Journal of Dermatology|October 30, 2024
Predictors of wound healing after surgical deroofing in Hidradenitis SuppurativaJames Pham, Tara Sholji, Lauren Guttman, et al.
Clinical and Experimental Dermatology|May 28, 2025
Evaluating the quality and readability of online information about hidradenitis suppurativa: a systematic reviewMarra Aghajani, Ericka Maye, Kate Burrell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2025
The evolving genetic landscape of ILVEN: A comprehensive reviewMarra Aghajani, Jessie Tong Lu, John W Frew, et al.
Photodermatology, Photoimmunology & Photomedicine|November 2, 2018
A retrospective cohort study of melanoma prevalence stratified by body site in a Regional Australian Population 1994-2017: Site-specific protective mechanismsDana Slape, Johnson Tang, Ruth Lawless, et al.
International Journal of Dermatology|October 22, 2019
Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysisKevin Phan, Artiene Tatian, Jane Woods, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 10, 2023
The impact of psoriasis biologic therapy on HIV viral load and CD4<sup>+</sup> cell counts in HIV-positive individuals: A real-world cohort studyJennifer Xu, Kyra Gill, Akshay Flora, et al.
Journal of the American Academy of Dermatology|June 12, 2023
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativaRebecca Jepsen, Chloe Edwards, Akshay Flora, et al.
The Australasian Journal of Dermatology|August 11, 2010
Categorizing immunoflourescence mapping in epidermolysis bullosa with pyloric atresia: Use as a broad prognostic indicatorJohn W Frew, Patricia J H Dopping-Hepenstal, John A McGrath
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Dermatology|September 16, 2021
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspectsDillon Mintoff, Farida Benhadou, Nikolai P Pace, et al.
Experimental Dermatology|March 8, 2020
Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?John W Frew, David Grand, Kristina Navrazhina, et al.
The Australasian Journal of Dermatology|October 30, 2024
Predictors of wound healing after surgical deroofing in Hidradenitis SuppurativaJames Pham, Tara Sholji, Lauren Guttman, et al.
Clinical and Experimental Dermatology|May 28, 2025
Evaluating the quality and readability of online information about hidradenitis suppurativa: a systematic reviewMarra Aghajani, Ericka Maye, Kate Burrell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2025
The evolving genetic landscape of ILVEN: A comprehensive reviewMarra Aghajani, Jessie Tong Lu, John W Frew, et al.
Photodermatology, Photoimmunology & Photomedicine|November 2, 2018
A retrospective cohort study of melanoma prevalence stratified by body site in a Regional Australian Population 1994-2017: Site-specific protective mechanismsDana Slape, Johnson Tang, Ruth Lawless, et al.
International Journal of Dermatology|October 22, 2019
Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysisKevin Phan, Artiene Tatian, Jane Woods, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 10, 2023
The impact of psoriasis biologic therapy on HIV viral load and CD4<sup>+</sup> cell counts in HIV-positive individuals: A real-world cohort studyJennifer Xu, Kyra Gill, Akshay Flora, et al.
Journal of the American Academy of Dermatology|June 12, 2023
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativaRebecca Jepsen, Chloe Edwards, Akshay Flora, et al.
The Australasian Journal of Dermatology|August 11, 2010
Categorizing immunoflourescence mapping in epidermolysis bullosa with pyloric atresia: Use as a broad prognostic indicatorJohn W Frew, Patricia J H Dopping-Hepenstal, John A McGrath
Pageof 10